Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA

Chang-Kyu Heo(Korea Research Institute of Bioscience and Biotechnology), Eun‐Wie Cho(Korea Research Institute of Bioscience and Biotechnology)
International Journal of Oncology
November 1, 2022
10.3892/ijo.2022.5448
Cited by 3

Related Papers

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
|Scientific Reports|2019|30
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
|Frontiers in Immunology|2023|9
S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern
|Vaccines|2024|2
Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loop
|Research Square|2020|0